Navigation Links
Statement of Robert K. Ross, M.D.
Date:1/28/2008

RE: PROGRESS OF HEALTH REFORM IN CALIFORNIA

LOS ANGELES, Jan. 28 /PRNewswire/ -- Dr. Robert K. Ross, the President and CEO of The California Endowment, today issued the following statement upon the failure of ABX1:

"Our hopes for achieving comprehensive health reform took a decidedly disappointing step backward in the wake of the Senate Health Committee's failure to take action on the health reform package known as ABX1.

"Rather than engage in unproductive finger-pointing about what went wrong, there is an immediate and urgent need for the Senate, Assembly, Governor and health care stakeholders to come together and determine what actually can be done this year to begin fixing California's broken health care system.

"While ABX1 as a whole isn't going anywhere, there are elements of the package that all sides agree on and we still have an opportunity to initiate reforms that will provide a roadmap and lay the groundwork for more significant progress in the years to come. After over a year of intense negotiations and discussions, there is consensus between business, labor, doctors, health providers, consumer advocates and policymakers on what steps can and should be taken.

"All sides agree that every child in California deserves to grow up healthy, and that we ought to ensure that all kids have health care coverage. There is agreement that our hospital system should be stabilized by increasing reimbursements for medical care through public programs, and that hospitals be assessed a provider tax to help finance health system improvements.

"We can't let these reforms fall to the wayside, and our leaders should take action without delay. We still have the opportunity to give Californians a much needed health care win. Progress can still be made this year, and inaction is simply not acceptable."


'/>"/>
SOURCE The California Endowment
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. NCPA Statement on Wal-Marts Entry Into the Pharmacy Benefit Market
2. Accuro Healthcare Solutions, Inc. Files Registration Statement for Proposed Initial Public Offering
3. Statement by Bruce Bodaken on Senate Health Committee Action
4. AASM statement on use of sleep medications
5. Bradley Pharmaceuticals Announces Filing of Definitive Proxy Statement for Special Meeting of Stockholders to Approve Merger With Nycomed
6. Statement of the Reverend Carlton W. Veazey, President and CEO of the Religious Coalition for Reproductive Choice, on the 35th Anniversary of Roe v. Wade
7. Statement of Steve Pasierb, President and CEO, Partnership for a Drug-Free America on New SAMHSA Study On Cough Medicine Abuse
8. Statement from AAJ President Kathleen Flynn Peterson on ATRAs Latest Attack on Civil Justice Attorneys
9. Statement From the Consumer Healthcare Products Association on the SAMHSA Findings on Cough Medicine Abuse
10. RxElite Registration Statement Suspended
11. RxElite Registration Statement Declared Effective by Securities and Exchange Commission
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... 2017 , ... "TransFlare 4K Mystique comes with 44 colorful mysterious transitions that ... Christina Austin - CEO of Pixel Film Studios. , TransFlare 4K Mystique contains ... lens flare and light leak transitions have a very high-dynamic range for super smooth ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a ... has set out for each of his children. “The Angel” is the creation of ... Music in New York City, and impassioned writer. , When asked of her new ...
(Date:1/20/2017)... ... January 20, 2017 , ... D R Burton Healthcare Products ... was featured in a study indicating superior performance against competitive products in secretion ... Three Oscillating Positive Expiratory Pressure Devices During Simulated Breathing“ was published in the ...
(Date:1/20/2017)... ... 2017 , ... “Knowledge is God’s Lighthouse”: a moving and colorful collection ... is the creation of published author, Gene Gaapf, a retired truck driver, and a ... have been writing since high school and have many different titles,” Gaapf mentions about ...
(Date:1/19/2017)... ... 2017 , ... Today, the Centers for Medicare & Medicaid Services (CMS) announced ... Models (APMs) in 2017. Clinicians who participate in APMs are paid for the quality ... the Administration’s effort to build a system that delivers better care and one in ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017  Abaxis, Inc. (NasdaqGS: ... point-of-care blood analysis instruments and consumables for the medical ... to discuss its financial results for the third quarter ... will be at 4:15 p.m. ET on Thursday, January ... the third quarter fiscal year 2017 after the market ...
(Date:1/19/2017)... , Jan. 19, 2017  Sensus Healthcare, ... device company specializing in the treatment of non-melanoma ... keloids, with superficial radiation therapy, today announced that ... year 2016 financial results on Thursday, February 2, 2017 ... will hold a conference call with the investment ...
(Date:1/19/2017)... Shire plc (LSE: SHP, NASDAQ: ... and Drug Administration (FDA) has acknowledged receipt of the ... for SHP465, a long-acting, triple-bead, mixed amphetamine salts formulation. ... for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is expected to ... the designated Prescription Drug User Fee Act (PDUFA) action ...
Breaking Medicine Technology: